Treatment of urgent bleeding in von Willebrand disease

Thrombosis Research

Volumn 120, Issue SUPPL. 1, 2007, Pages

  Gill, Joan Cox ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

DDAVP; Desmopressin; Factor VIII; Replacement therapy; Ristocetin cofactor; von Willebrand disease; von Willebrand factor; VWD; VWF

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; DESMOPRESSIN ACETATE; PLASMA PROTEIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; CIRCULATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DOSE CALCULATION; DRUG DOSE INCREASE; DRUG FORMULATION; DRUG MECHANISM; FLUSHING; HEADACHE; HUMAN; HYPONATREMIA; MOUTH CAVITY; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN STABILITY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SUBENDOTHELIUM; TACHYCARDIA; THROMBOCYTE ADHESION; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT RESPONSE; VON WILLEBRAND DISEASE;

ACUTE DISEASE; HEMORRHAGE; HEMOSTATICS; HUMANS; VON WILLEBRAND DISEASE;

EID: 34249883835     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.03.013     Document Type: Article

References (25)

1. Gill J.C. Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin North Am 18 (2004) 1277-1299
2. Sadler J.E. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 71 (1994) 520-525
3. Sadler J.E. New concepts in von Willebrand disease. Annu Rev Med 56 (2005) 173-191
4. Sadler J.E., Budde U., Eikenboom J.C., Favaloro E.J., Hill F.G., Holmberg L., et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4 (2006) 2103-2114
5. Thompson A.R., Gill J.C., Ewenstein B.M., Mueller-Velten G., Schwarz B.A., and Humate-P Study Group. Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/vWF concentrate (Humate-P). Haemophilia 10 (2004) 42-51
6. Gill J.C., Ewenstein B.M., Thompson A.R., Mueller-Velten G., Schwartz B.A., and Humate-P Study Group. Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/vWF concentrate (Humate-P): use of the ristocetin cofactor assay (vWF:RCo) to measure potency and to guide therapy. Haemophilia 9 (2003) 688-695
7. Mannucci P.M., Chediak J., Hanna W., Byrnes J., Marlies L., Ewenstein B.M., et al. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 99 (2002) 450-456
8. Lillicrap D., Poon M.C., Walker I., Xie F., Schwartz B.A., and Association of Hemophilia Clinic Directors of Canada. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, Haemate P/Humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost 87 (2002) 224-230
9. Srivastava A., Mathews V., Bhurani D., Baidya S., and Chandy M. Successful surgical hemostasis in patients with von Willebrand disease following infusion of KoateDVI. Thromb Haemost 87 (2002) 541-543
10. Mannucci P.M. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 90 (1997) 2515-2521
11. Gill J.C., Ottum M., and Schwartz B. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease. J Pediatr 140 (2002) 595-599
12. Mannucci P.M., Canciani M.T., Rota L., and Donovan B.S. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 47 (1981) 283-293
13. Lethagen S., Harris A.S., Sjorin E., and Nilsson I.M. Intranasal and intravenous administration of desmopressin: effect on FVIII/vWF, pharmacokinetics and reproducibility. Thromb Haemost 58 (1987) 1033-1036
14. de la Fuente B., Kasper C.K., Rickles F.R., and Hoyer L.W. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. Ann Intern Med 103 (1985) 6-14
15. Federici A.B., Mazurier C., Berntorp E., Lee C.A., Scharrer I., Goudemand J., et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 103 (2004) 2032-2038
16. Mazurier C., Gaucher C., Jorieux S., and Goudemand M. Biological effect of desmopressin in eight patients with type 2N ('Normandy') von Willebrand disease. Collaborative Group. Br J Haematol 88 (1994) 849-854
17. Mannucci P.M. Treatment of von Willebrand's disease. N Engl J Med 351 (2004) 683-694
18. Mannucci P.M., Duga S., and Peyvandi F. Recessively inherited coagulation disorders. Blood 104 (2004) 1243-1252
19. ®) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand's disease. Haematologica 88 (2003) 1279-1283
20. Mannucci P.M., Cancian M.T., Rota L., and Donovan B.S. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease. Br J Haematol 47 (1981) 283-293
21. Casonato A., Steffan A., Pontara E., Zucchetto A., Rossi C., De Marco L., et al. Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost 81 (1999) 224-228
22. Smith T.J., Gill J.C., Ambruso D.R., and Hathaway W.E. Hyponatremia and seizures in young children given DDAVP. Am J Hematol 31 (1989) 199-202
23. Bertholini D.M., and Butler C.S. Severe hyponatraemia secondary to desmopressin therapy in von Willebrand's disease. Anaesth Intensive Care 28 (2000) 199-201
24. Budde U., Metzner H.J., and Müller H.-G. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. Semin Thromb Hemost 32 (2006) 626-635
25. Sindet-Pedersen S., Ramstrom G., Bernvil S., and Blomback M. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 320 (1989) 840-843